Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q1 2024 · 10-Q
Revenue$279.31M$279.31M+0.8% vs Q1 2023 Net Income$53.28M$53.28M−3.6% vs Q1 2023 EPS Diluted$1.06$1.06−2.8% vs Q1 2023 Gross Profit$154,673,000−3.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flow$48,087,000−17.4% Free Cash Flowderived$46,610,000−18.5% Margins · derivedGross margin55.4%−2.4 pt vs Q1 2023
Operating margin30.5%−0.9 pt vs Q1 2023
Net margin19.1%−0.9 pt vs Q1 2023
ended Jun 30, 2023 · filed Aug 3, 2023 · 34 d after period end